Neumora Therapeutics is trading at $0.72, up 5.59% in after-hours trading; no clear company-specific catalyst was identified for September 25. - The provided price context shows a $0.68 regular-session close on September 25. - The latest company press releases surfaced were from earlier dates; no reliable after-hours volume was available. - Major U.S. indexes rose during the session, but available information does not establish that broad-market strength caused the after-hours move.